DEVELOPMENT AND EVALUATION OF BIOADHESIVE MUCOSAL DOSAGE FORMS OF PILOCARPINE HCL FOR XEROSTOMIA THERAPY
Objective: Saliva maintains vital mouth functions and acts as a barrier to dental health. Xerostomia, which is characterised as a feeling of dry mouth, adversely affects the patient’s quality of life. Palliative therapies, such as sialagogues, form the based on treatment of xerostomia. The FDAapprov...
Saved in:
| Main Authors: | Özlem Akbal Dağıstan, Nur Sena Başarır, Sinem Yaprak Karavana, Ayça Yıldız Peköz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2025-03-01
|
| Series: | Sabiad |
| Subjects: | |
| Online Access: | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/7F807DCE4D4843D49CF03BBAFE3900D5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Evaluation of Salivary Flow Rate in Oral Submucous Fibrosis Patients before and after Transcutaneous Electric Nerve Stimulation: A Research Protocol
by: Tanaya Teredesai, et al.
Published: (2024-12-01) -
Combination Low-Dose Pilocarpine/Diclofenac Sodium and Pilocarpine Alone for Presbyopia: Results of a Randomized Phase 2b Clinical Trial
by: Farid M, et al.
Published: (2024-11-01) -
Treatment of xerostomia in Sjögren’s syndrome – what effect does it have on the oral microbiome?
by: Damian Muszyński, et al.
Published: (2025-04-01) -
Study of influence of base-vehicle on biological activity of vasopressin in the transbuccal dosage forms
by: Al Nasir Eiad, et al.
Published: (2019-12-01) -
Labial salivary gland biopsy: a crucial method for confirming seronegative Sjogren’s syndrome—a case report
by: Satyasai S. G. Romala, et al.
Published: (2024-12-01)